baber/WOPTO huggingface dataset:
Patent DE-970372-T1 (DE)
Inventor: PRUSINER B
IPC: A61P25/28
Filed: 1998-02-20
Abstract: The invention provides an assay method for determining the presence of a PrP<Sc> form of a PrP protein in a sample comprising a first PrP<C> conformation of the protein and a second PrP<Sc> conformation of the protein, the method comprising contacting a first portion of the sample with a binding partner, said binding partner having a higher affinity for the PrP<C> conformation than the PrP<Sc> conformation, and determining a first concentration; treating a second portion of the sample to change the PrP<Sc> conformation into a conformation with a higher binding affinity for the binding partner; contacting the treated second portion of the sample with the binding partner to determine a second concentration; adjusting the second concentration to provide an adjusted concentration which adjustment compensates for increased affinity of the PrP<C> conformation for the binding partner resulting from the treating; and comparing the first concentration with the adjusted concentration to determine the presence of protein in the PrP<Sc> conformation.
Patent DE-1111550-T1 (DE)
Inventor: TORBJOERN OTTOSSON S- VAESTERA
IPC: G05B23/02
Filed: 1999-12-23
Abstract: A method for monitoring the condition of an individual machine belonging to a selected class of machines, wherein operational data significant for that condition are compared with a reference data according to a predetermined criterion, and wherein an output signal indicating the result of the comparison is formed, the method comprising the steps of:   creating a first set of operational data for the selected class of machines on the basis of data stored in a reference database, creating a second set of operational data for the individual machine based on measurements performed on that machine, forming a first reference data in dependence on values of at least a selection of said first set of operational data, forming a second reference data in dependence on values of said second set of operational data, comparing said second reference data with said first reference data in accordance with the first predetermined criterion, and forming the output signal in dependence on the result of said comparison.   <IMAGE>
Patent ES-2208144-T1 (ES)
Title: Metodo y aparato para inflar y sellar almohadillas para embalajes.
Inventor: PERKINS ANDREW
IPC: B65D81/07
Filed: 2001-08-06
Abstract: Un método para fabricar almohadillas rellenas de aire para embalajes, partiendo de una bobina de material laminar premoldeado, que presenta un canal para inyectar el aire dispuesto longitudinalmente, así como una serie cámaras que se pueden inflar y están comunicadas con el canal de inyección a través de pasos de entrada situados lateralmente; el método comprende los siguientes pasos: hacer avanzar una bobina de material laminar premoldeado a lo largo de una vía, inflar las cámaras que presenta el material mediante el canal de inyección a medida que el material se desplaza por la vía, y hacer pasar el material laminar por la periferia de un rodillo sellador y en contacto deslizante directo con un elemento sellador por calor para sellar herméticamente los pasos de entrada de aire.
Patent ES-2100832-T1 (ES)
Inventor: ANTHOINE-MILHOMME DIDIER
IPC: G01G3/14
Filed: 1996-05-07
Abstract: The weight sensor has a single block of elastic metal of constant thickness which is cut to form a test bar (1) and a supporting base (3). The test bar which is supported from one side of the base (3a) has a cross piece (4c) and parallel side bars (4a,4b). The test bar has an upper bearing surface (4) designed to take the weight being measured and is entirely within the supporting surface (5) of the base producing mechanical equilibrium. Strain gauges (2) are fixed to the test bar and measure the deflection under the weight being measured.
Patent ES-2161202-T1 (ES)
Title: Un aparato para terapia fisica con una interface interactiva y metodo para configurar el mismo.
Inventor: POHL JEFF K
IPC: A61N1/32
Filed: 1996-06-20
Abstract: SE FACILITA UN APARATO DE TERAPIA FISICA RECONFIGURABLE Y METODO PARA PROPORCIONAR ESTIMULOS SELECCIONADOS POR OPERADOR A UN PACIENTE. EL APARATO TIENE PREFERIBLEMENTE UN APLICADOR DE TERAPIA FISICA QUE INCLUYE UN TRANSDUCTOR PARA APLICAR UN TRATAMIENTO TERAPEUTICO A UN PACIENTE, Y UNA MEMORIA PARA ALMACENAR DATOS DE IDENTIFICACION REPRESENTATIVOS DE UNA VARIEDAD DE ENFERMEDADES FISICAS PARA CADA UNA DE LAS DIFERENTES AREAS CORPORALES HUMANAS Y UN CONJUNTO DE PARAMETROS OPERATIVOS DEL TRANSDUCTOR ASOCIADOS A CADA ENFERMEDAD FISICA PREDETERMINADA Y CADA AREA CORPORAL PREDETERMINADA. EL APARATO TAMBIEN TIENE UNA PANTALLA DE VISUALIZACION DE LA ENFERMEDAD QUE RESPONDE AL DISPOSITIVO DE MEMORIA PARA VISUALIZAR AL MENOS UNO DE LOS DATOS DE IDENTIFICACION REPRESENTATIVOS DE UNA VARIEDAD DE ENFERMEDADES FISICAS QUE SE ASOCIAN CON AL MENOS UNA DE LAS AREAS CORPORALES HUMANAS. UN SELECTOR DE ENFERMEDAD SE HALLA COLOCADO EN COMUNICACION ELECTRICA CON AL MENOS EL DISPOSITIVO DE MEMORIA Y RESPONDE A LASELECCION DE OPERADOR DE UNA DE LAS ENFERMEDADES FISICAS IDENTIFICADAS QUE SE HALLAN ASOCIADAS CON LAS AREAS CORPORALES HUMANAS PARA OBTENER LOS PARAMETROS OPERACIONALES DEL TRANSDUCTOR ASOCIADO. EL APARATO ADEMAS TIENE UN RECONFIGURADOR DEL TRANSDUCTOR COLOCADO EN COMUNICACION ELECTRICA CON EL TRANSDUCTOR DEL APLICADOR QUE RESPONDE AL SELECTOR DE ENFERMEDAD PARA RECONFIGURAR EL TRANSDUCTOR Y PROPORCIONAR EL TRATAMIENTO TERAPEUTICO A LA PARTE CORPORAL IDENTIFICADA CONFORME A LOS PARAMETROS OPERACIONALES DEL TRANSDUCTOR OBTENIDOS.
Patent ES-2140369-T1 (ES)
Title: Dispositivo para el frenado de motores electricos.
Inventor: MLINAR DANIEL
IPC: F16D55/00
Filed: 1999-05-28
Abstract: UN FRENO DE PRESION DE RESORTE PARA MOTORES ELECTRICOS POSEE UN DISCO DE FRENADO (9) ACOPLADO CON EL EJE DE ROTOR DEL MOTOR ELECTRICO EN SU GIRO, ESTANDO EQUIPADO EN AMBOS LADOS CON REVESTIMIENTOS DE FRENADO (8) DE FORMA ANULAR Y DISPONIENDOSE ENTRE UNA CHAPA DE ROZAMIENTO (10) SUJETA EN EL ESCUDO DE COJINETE (1) DEL MOTOR ELECTRICO Y UN INDUCIDO (7). EL INDUCIDO (7) SE CARGA MEDIANTE AL MENOS UN RESORTE DE PRESION (11) EN DIRECCION SOBRE LA CHAPA DE ROZAMIENTO (10), DE TAL FORMA QUE SUJETA EL DISCO DE FRENADO (9) ENTRE LA CHAPA DE ROZAMIENTO (10) Y EL MISMO, DE MODO QUE EL DISCO DE FRENADO (9) FRENA EL ROTOR ACOPLADO CON EL A TRAVES DEL EJE DE ROTOR. EN EL ACCIONAMIENTO DEL MOTOR ELECTRICO SE ALIMENTA UNA BOBINA (6) CON CORRIENTE, DONDE EL CAMPO MAGNETICO DEL INDUCIDO (7) GENERADO CON ELLA TRACCIONA BAJO PRESIONADO CONJUNTO DE AL MENOS UN RESORTE (12) A PARTIR DE LA CHAPA DE ROZAMIENTO (10), DE TAL FORMA QUE PUEDE GIRAR LIBREMENTE EL DISCO DE FRENADO (9) ENTRE EL INDUCIDO (7) Y LA CHAPA DEROZAMIENTO (10).
Patent CY-1106949-T1 (CY)
Inventor: MAILLAND FEDERICO
IPC: A61K9/70
Filed: 2007-10-22
Abstract: A composition comprises at least one herb extract from Equisetum and at least one film-forming agent. ACTIVITY : None given. MECHANISM OF ACTION : None given.
Patent CY-1112734-T1 (CY)
Inventor: SANDIG VOLKER
IPC: C12N5/16
Filed: 2012-04-09
Abstract: The present invention provides a potent expression cell line having stably integrated into its genome a gene encoding a specific heterologous regulator protein. Said cell line is particularly useful for protein and virus production.
Patent CY-1114803-T1 (CY)
Title: Παραγωγα πυριμιδινο σουλφοναμιδιου ως ρυθμιστες υποδοχεων χημειοκινης
Inventor: CHESHIRE DAVID RANULF
IPC: C07D417/12
Filed: 2014-01-15
Abstract: Μια ένωση του τύπου (1), ή ένα φαρμακευτικώς αποδεκτό άλας, διαλύτωμα ή in vivo υδρολύσιμος εστέρας αυτής και φαρμακευτικές συνθέσεις που τα περιλαμβάνουν, όλα για χρήση στη θεραπευτική αγωγή μεσολαβούμενων από χημειοκίνη ασθενειών και διαταραχών.
Patent CY-1114902-T1 (CY)
Title: Ανταγωνιστες cgrp υποδοχεα
Inventor: LUO GUANGLIN
IPC: C07D401/12
Filed: 2014-02-18
Abstract: Η αποκάλυψη γενικά σχετίζεται με τις νέες ενώσεις του τύπου (I), συμπεριλαμβανομένων των φαρμακευτικά αποδεκτών αλάτων, οι οποίες δρουν ως ανταγωνιστές του CGRP υποδοχέα. Η αποκάλυψη επίσης σχετίζεται με φαρμακευτικές συνθέσεις και με μεθόδους χρήσης των ενώσεων στην αγωγή διαταραχών σχετιζόμενων με CGRP, για παράδειγμα ημικρανίας και άλλων πονοκεφάλων, νευρογενούς αγγειοδιαστολής, νευρογενούς φλεγμονής, θερμικού τραυματισμού, κυκλοφορικής καταπληξίας, έξαψης συνδεόμενης με εμμηνόπαυση, φλεγμονωδών παθήσεων αεραγωγών όπως άσθματος, και χρόνιας αποφρακτικής πνευμονοπάθειας (COPD).
Patent CY-1119497-T1 (CY)
Title: Συσκευη ψησιματος με ενα πλαισιο και φορμες ψησιματος
Inventor: RAUCH GERALD
IPC: A21B3/13
Filed: 2017-07-10
Abstract: Περιγράφεται μια συσκευή ψησίματος με μερικές τοποθετούμενες από πάνω σε ένα πλαίσιο (1) φόρμες ψησίματος (2), οι οποίες έχουν στοιχεία συγκράτησης (5) που πιάνουν πάνω από απέναντι αλλήλων κείμενα σκέλη (3) του πλαισίου (1). Για να μπορούν οι επί μέρους φόρμες ψησίματος (2) να αντικαθίστανται με απλό τρόπο, χωρίς να πρέπει να εγκαταλείπεται μια ασφαλής συγκράτηση των φορμών ψησίματος (2) στο πλαίσιο (1), προτείνεται, μεταξύ των διαμορφωμένων με ιδιότητες ελατηρίου στοιχείων συγκράτησης (5) και των σκελών του πλαισίου (3) που πιάνονται από πάνω από τα στοιχεία συγκράτησης (5) να προβλέπονται στοιχεία ασφάλισης με σώματα ασφάλισης (8) που εμπλέκονται σε εσοχές ασφάλισης (7).
Patent CY-1119298-T1 (CY)
Title: Διαδικασια για παραγωγη μεγαλης κλιμακας του 1-(2-bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-1h-1 νdole dimesylate mono-enyδρου
Inventor: NIROGI RAMAKRISHNA
IPC: C07D209/14
Filed: 2017-08-28
Abstract: Μία διαδικασία για την υιοθέτηση κατασκευής μεγάλης κλίμακας του 1[(2-bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-1H-indole dimesylate μονό-ένυδρου, που είναι ένας επιλεκτικός ανταγωνιστής υποδοχέα 5-ΗΤ6 που προορίζεται για την συμπτωματική θεραπεία της ασθένειας Alzheimer και άλλων διαταραχών της μνήμης και της νόησης όπως υπέρ-κινητικότητα έλλειψης προσοχής, ασθένεια Parkinson και Σχιζοφρένεια.
Patent CY-1119335-T1 (CY)
Title: Ποντικοι με περιορισμενη βαρια αλυσιδα ανοσοσφαιρινης
Inventor: MACDONALD LYNN
IPC: C12N15/85
Filed: 2017-09-12
Abstract: Παρέχονται ποντικοί, διαθέτοντες έναν περιορισμένο τόπο βαριάς αλυσίδας ανοσοσφαιρίνης, ο οποίος τόπος χαρακτηρίζεται από ένα μεμονωμένο, πολυμορφικό, ανθρώπινο VH γονιδιακό τμήμα, μια πληθώρα ανθρώπινων DH γονιδιακών τμημάτων και μια πληθώρα JH γονιδιακών τμημάτων. Παρέχονται μέθοδοι δημιουργίας αλληλουχιών αντισωμάτων, που προσδένουν έναν αντιγόνο (π.χ. ένα ιικό αντιγόνο). Οι μέθοδοι περιλαμβάνουν ανοσοποίηση ενός ποντικού με ένα αντιγόνο ενδιαφέροντος, ο οποίος ποντικός διαθέτει ένα μεμονωμένο, ανθρώπινο VH γονιδιακό τμήμα, μια πληθώρα ανθρώπινων DH γονιδιακών τμημάτων και μια πληθώρα JH γονιδιακών τμημάτων, στον ενδογενή τόπο βαριάς αλυσίδας ανοσοσφαιρίνης.
Patent CY-1119901-T1 (CY)
Title: Αναστολεις απομεθυλασων ιστονων
Inventor: KANOUNI TOUFIKE
IPC: C07D413/12
Filed: 2018-02-09
Abstract: Η παρούσα εφεύρεση σχετίζεται γενικά με συνθέσεις και μεθόδους για την αγωγή του καρκίνου και της νεοπλασματικής νόσου. Παρέχονται στο παρόν υποκατεστημένες ενώσεις παραγώγων 3-αμινοπυριδίνης, υποκατεστημένες ενώσεις 3-αμινοπυριδαζίνης, και φαρμακευτικές συνθέσεις που περιλαμβάνουν τις εν λόγω ενώσεις. Οι εν θέματι ενώσεις και συνθέσεις είναι χρήσιμες για την αναστολή των απομεθυλασών των ιστονών. Περαιτέρω, οι ενώσεις και οι συνθέσεις της εφεύρεσης είναι χρήσιμες για τη θεραπεία του καρκίνου, όπως του καρκίνου του προστάτη, του καρκίνου μαστού, του καρκίνου ουροδόχου κύστεως, καρκίνο πνεύμονα και/ή μελάνωμα και τα παρόμοια.
Patent CY-1121265-T1 (CY)
Title: Παραγωγα πιπεριδινονης ως αναστολεις της mdm2 για την θεραπευτικη αγωγη του καρκινου
Inventor: BARTBERGER MICHAEL DAVID
IPC: C07D401/04
Filed: 2019-02-13
Abstract: Η παρούσα εφεύρεση παρέχει ενώσεις αναστολέων της MDM2 του Τύπου ΙΕ, οι οποίες ενώσεις είναι χρήσιμες ως θεραπευτικοί παράγοντες, ιδιαίτερα για την θεραπευτική αγωγή καρκίνων. Η παρούσα εφεύρεση σχετίζεται επίσης με φαρμακευτικές συνθέσεις οι οποίες περιέχουν έναν αναστολέα της MDM2.
Patent CY-1121432-T1 (CY)
Title: Υποκατεστημενα αμινοτριαζολια χρησιμα ως αναστολεις ανθρωπινης χιτινασης
Inventor: MAZUR MARZENA
IPC: A61P35/00
Filed: 2019-03-15
Abstract: Αποκαλύπτονται ενώσεις αμινοτριαζολίου υποκατεστημένες με έναν δακτύλιο πιπεριδινυλίου ο οποίος είναι ο ίδιος υποκατεστημένος με έναν ετεροκυκλικό δακτύλιο. Οι ενώσεις αυτές είναι αναστολείς της όξινης χιτινάσης των θηλαστικών και της χιτοτριοσιδάσης. Αποκαλύπτονται επίσης μέθοδοι χρήσης των ενώσεων στην αγωγή αντιδράσεων άσθματος που οφείλονται σε αλλεργιογόνα, όπως επίσης οξέων και χρόνιων φλεγμονωδών νόσων, αυτοάνοσων νόσων, οδοντικών νόσων, νευρολογικών νόσων, μεταβολικών νόσων, ηπατικών νόσων, συνδρόμου πολυκυστικών ωοθηκών, ενδομητρίωσης και καρκίνου.
Patent GR-950300077-T1 (GR)
Title: Process for softening/stuffing leather and fur skins.
Inventor: DAHMEN KURT
IPC: C14C9/00
Filed: 1996-01-31
Abstract: PCT No. PCT/EP93/02880 Sec. 371 Date Jun. 9, 1995 Sec. 102(e) Date Jun. 9, 1995 PCT Filed Oct. 19, 1993 PCT Pub. No. WO94/10346 PCT Pub. Date May 11, 1994The invention relates to a process for the fat liquoring/softening of leathers and furs by treatment with an aqueous dispersion of a copolymer obtainable by polymerization of a) maleic anhydride, b) C12-C30 alpha-olefins, esters of (meth)acrylic acid and/or maleic acid with C12-C30 alcohols and c) optionally, further hydrophilic, ethylenically unsaturated monomers which are copolymerizable with a) and b), reaction of the anhydride groups with monovalent alcohols comprising at least one ether functionality, and partial neutralization or hydrolysis of the residual acid or anhydride groups and manufacture of a flowable dispersion having an active substance content of at least 40%-wt.
Patent HR-P20100473-T1 (HR)
Inventor: AZPIROZ AINTZANE ZABALETA
IPC: A61K39/395
Filed: 2010-08-30
Abstract: Imunostimulatorna kombinacija za profilaksu i liječenje hepatitisa C, naznačena time što sadrži: a)	Poli(I:C) koji djeluje kao agonist TLR3, b)	agonist CD40 ili sekvenca DNK koja ga kodira, i c)	polipeptid, koji sadrži NS3 protein virusa hepatitisa C, ili fragment navedenog NS3 proteina sa kapacitetom za indukciju CD8+ i CD4+ odgovora. Patent sadrži još 17 patentnih zahtjeva.
Patent HR-P20110272-T1 (HR)
Title: Nitrogen-containing heteroaryl compounds and their use in increasing endogeneous erythropoietin
Inventor: AREND MICHAEL P
IPC: C07D217/00
Filed: 2011-04-14
Abstract: The present invention relates to compounds I suitable for use in mediating hypoxia inducible factor and for treating erythropoietin-associated conditions by increasing endogenous erythropoietin  in vitro  and  in vivo .
Patent HR-P20110897-T1 (HR)
Title: Device for draining surface water with fire protection
IPC: E04D13/04
Filed: 2011-11-30
Abstract: Device consists of installation pot, installation flange and protection hood (12). The fire protection element (20') is integrated or inserted into a body (13) that is designed in the protection hood. The body, which is inserted or designed in the protection hood lies opposite to the drain tube of the installation pot, has a cover plate (14). The cover plate partially covers fire protection element opposite the drain tube of the installation pot.
Patent SI-1165564-T1 (SI)
Title: Process for preparing inhibitors of nucleoside metabolism
Inventor: FURNEAUX RICHARD HUBERT
IPC: C07D491/056
Filed: 2000-04-07
Abstract: The invention provides a compound of the formula:   
wherein Y is an unsubstituted or substituted alkyl or arylalkyl group having 1 to 8 carbon atoms, as well as a process of preparing said compound.  The invention also provides a process of preparing the compound 3H,5H-pyrrolo[3,2-d]pyrimidin-4-one, comprising the step of reacting a compound of the formula (A) defined above with a reagent capable of delivering a formyl equivalent.  The invention also provides a process of preparing the compound 2-amino-3 H ,5 H -pyrrolo[3,2- d ]pyrimidin-4-one, comprising the step of reacting the compound 2-(N-dimethylaminomethylene)amino-6-(2-dimethylaminovinyl)-5-nitropyrimid-4-one with a reagent capable of reducing the nitro group, to produce the compound 2-amino-3 H ,5 H- pyrrolo[3,2- d ]pyrimidin-4-one.
Patent SI-1438961-T1 (SI)
Title: Bioequivalent composition of itraconazole dispersed in a hydrophilic polymer
Inventor: SETH PAWAN
IPC: A61K31/496
Filed: 2003-01-14
Abstract: The invention provides an itraconazole composition comprising itraconazole dispersed in a hydrophilic polymer, and, optionally, a surfactant, having a dissolution at 30 minutes between 10 and 40%, at 45 minutes between 25 and 80%, at 60 minutes between 60 and 95%, at 90 minutes at least 80%, as measured using the type II paddle method at 100 rpm according to the US Pharmacopoeia, in a dissolution medium comprised of 1000 ml HCl 0.1N. <??>The invention also provides a process for manufacturing this composition.
Patent SI-2353608-T1 (SI)
Title: Polypeptide-vaccines for broad protection against hypervirulent meningococcal lineages
Inventor: PIZZA MARIAGRAZIA
IPC: C07K14/00
Filed: 2003-10-02
Abstract: A small number of defined antigens can provide broad protection against meningococcal infection, and the invention provides a composition which, after administration to a subject, is able to induce an antibody response in that subject, wherein the antibody response is bactericidal against two or three of hypervirulent lineages A4, ET 5 and lineage 3 of  N.meningitidis  serogroup B. Rather than consisting of a single antigen, the composition comprises a mixture of 10 or fewer purified antigens, and should not include complex or undefined mixtures of antigens such as outer membrane vesicles. Five protein antigens are used in particular: (1) a 'NadA' protein; (2) a '741' protein; (3) a '936' protein; (4) a '953' protein; and (5) a '287' protein. Oligomeric 'NadA' is particularly useful.
Patent SI-1788391-T1 (SI)
Title: Biosensor apparatus and methods of use
Inventor: RYLATT DENNIS
IPC: G01N27/327
Filed: 2006-11-21
Abstract: Disclosed herein are methods and devices for detecting the presence of an analyte of interest. A biosensor device can include a reaction chamber and an electrochemical detection chamber. The reaction chamber can include at least one immobilized binding site and a probe conjugate adapted to bind to at least one of the target analyte and the immobilized binding site, while the detection chamber can include electrodes for detecting an electrochemical reaction. If present, the target analyte in the fluid sample results in a change in the amount of probe conjugate bound in the reaction chamber, which can be detected electrochemically in the detection chamber.
Patent SI-2200196-T1 (SI)
Title: Apparatus for transmitting and receiving a signal and method of transmitting and receiving a signal.
Inventor: KO WOO SUK
IPC: H04L27/26
Filed: 2009-06-03
Abstract: The present invention relates to method of transmitting and receiving signals and a corresponding apparatus. One aspect of the present invention relates to a method of time deinterleaving the preambles of the received signals with a full deinterleaving depth.
Patent SI-2834239-T1 (SI)
Title: Heterobicyclic compounds as beta-lactamase inhibitors
Inventor: MCGUIRE HELEN
IPC: C07D471/00
Filed: 2013-04-02
Abstract: The present invention is directed to compounds which are beta-lacatamase inhibitors. The compounds and their pharmaceutically acceptable salts, are useful in combination with beta-lactam antibiotics, or alone, for the treatment of bacterial infections, including infections caused by drug resistant organisms, including multi-drug resistant organisms. The present invention includes compounds according to formula (Ia): or a pharmaceutically acceptable salt thereof, wherein the values of R1, R2, R3 and R4 are described herein.
Patent SI-3029996-T1 (SI)
Title: Target cell selection during handover
Inventor: BIYANI NIDHI DEEPAK
IPC: H04W36/00
Filed: 2015-11-30
Abstract: Systems and methods for selecting a target cell during a handover procedure at a serving cell are disclosed. A plurality of neighbor cells is detected. A plurality of Measurement Reports (MRs) comprising Reference Signal Received Power (RSRP) values of the plurality of neighbor cells is received from the user equipment (UE). Incremental weightages are assigned to the RSRP values of each MR of the plurality of MRs. Based on the RSRP and the incremental weightages assigned, a weighted average of the RSRP values for each neighbor cell is calculated. Based on the weighted average, a target cell is selected to send a handover request. A target cell is selected from the plurality of neighbor cells based on the weighted average of the RSRP values. the target cell is selected based on a periodic interval time and scaling factors as per UE speed to determine the handover.
Patent DE-3686393-T2 (DE)
Inventor: SHOR PETER SCOTT
IPC: C25C1/00
Filed: 1986-05-28
Granted: 1993-04-01
Abstract: A novel gold purification method is provided which comprises electrolyzing gold into a novel pregnant electrolyte, segregating the dissolved gold ions from the cathode by a semipermeable barrier, separating insoluble impurities from the gold-containing liquidus, and then selectively reducing the gold to metallic form from the liquidus by a selective chemical reducing agent. The electrolyte is impregnated with a catalyst for leveling the overvoltage of gold and preferably contains a peroxide or a nascent oxygen source. A unitary apparatus for the method is provided.
Patent DE-3689716-T2 (DE)
Inventor: WALLACE DAVID
IPC: G01S15/10
Filed: 1986-09-25
Granted: 1994-07-07
Abstract: Disclosed is a digital ultrasonic instrument for measuring the corneal thickness (often referred to as a pachymeter) and for measuring the axial length of the eye (often referred to as a biometric ruler). A number representing corneal thickness or axial length is displayed digitally on a liquid crystal display. The pachymeter incorporates a 20 MHz solid phase piezoelectric transducer, a microprocessor, a gate array, a hybrid analog receiver circuit, a liquid crystal display and four batteries. When axial length is measured, the instrument operates as a biometric ruler, a 10 MHz transducer is used and the software in the microprocessor is modified. Ultrasonic echoes generated by the transducer and various interfaces in the eye are sampled at the rate of 40 MHz which results in equal or greater sensitivity, resolution and accuracy as compared to other pachymeters and biometric rulers currently available. The 40 MHz sample rate is accomplished by use of a grey code counter and a binary counter, each of which is sampled twice after an ultrasonic echo is detected. The two grey code samples are compared to determine a valid sample period. A counter value obtained during a valid sample period is recorded in a shift register and compared to subsequent counter values corresponding to subsequent ultrasonic echoes. The apparatus for correlating ultrasonic echoes with particular counter values assures that the counter will be sampled at a point in time when the counter is stable as opposed to being in a state of transition. The apparatus allows for a counter accuracy of 25 ns.